Suite 2, Level 11, 385 Bourke Street, Melbourne VIC 300 Australia Prescient Therapeutics Limited T - +61 3 9692 7222/F - +613 9077 9233/W – ptxtherapeutics.com ABN 56 006 569 106 ...
Share Purchase Plan Cleansing Notice
Filed with ASX ·
6ix hasn’t read this filing yet.
Prescient Therapeutics Limited on 6ix
In the deck
Earlier from Prescient Therapeutics
- Proposed issue of securities - PTX
- Prescient Therapeutics Launches Share Purchase Plan for $7m
- Appendix 4E and 2026 Annual Report
- Appendix 4G and Corporate Governance Statement
- June 2026 Quarterly Update and Appendix 4C
Later from Prescient Therapeutics
- Prescient Therapeutics Opens SPP to Raise $7m Today
- Prescient Share Purchase Plan Investor Presentation
- PTX-100 CTCL Phase 2a study reaches review milestone
- Prescient Therapeutics - Extension of Share Purchase Plan
- Update - Proposed issue of securities - PTX
Follow Prescient Therapeutics into a list and get an email when it puts out news.
Follow Prescient Therapeutics